Corcept Therapeutics (CORT) earnings, Jul 29, 2026: EPS +24%, stock +27.3%
In brief
Corcept Therapeutics reported on Jul 29, 2026. Earnings per share changed +24% year over year, 1,383.3% above the estimate; revenue +32%. The stock opened with a +20.5% gap and closed the day +27.3% (Jul 30, 2026). The stock is now 43.3% below its 52-week high, −6.5% over 12 months. Next report: Mar 2, 2027.
EPS vs estimate+1,383.3%
EPS, YoY+24%
Revenue, YoY+32%
Gap · day+20.5% · +27.3%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Jul 29, 2026 | +20.5% | +27.3% |
Next-quarter estimates, ratings and the CORT chart are in the terminal.
Open the terminalFAQ
When is Corcept Therapeutics's next earnings report?
Mar 2, 2027. The date comes from daily data and is corrected if the company moves it.
How did Corcept Therapeutics stock react to the report?
Opening gap +20.5%, day's result +27.3%.
Did Corcept Therapeutics's earnings grow?
Earnings per share rose 24% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.